Sample Analyzer Bacterial Identification via Flow Cytometry

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting bacteria in clinical samples, such as urine, are slow and lack the ability to differentiate between multiple types of bacteria and provide timely information on bacterial changes, making it difficult to diagnose urinary tract infections and assess treatment effectiveness.

Innovation Solution

A sample analyzer that uses a light source and detector to emit and measure scattered light and fluorescence from bacteria, generating particle data to determine the presence of urinary tract infections and changes in bacterial types, with a controller displaying histograms and change information to aid in diagnosis and treatment monitoring.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If culture method is used to detect bacteria, then bacteria types and numbers can be identified, but it takes several days for colonies to form, lacking promptness

Engineering Contradiction:
Improvebacteria identification accuracyVSAvoiddetection time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces the biological culture method with a flow cytometry-based optical detection system. Instead of relying on bacterial colony formation through cultivation, the system uses light scattering and fluorescence properties of bacteria to achieve rapid identification, substituting biological processes with physical measurement techniques.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the detection parameters from colony morphology and growth rate (culture-based) to light scattering intensity and fluorescence characteristics (optical properties). This parameter transformation enables rapid detection while maintaining identification accuracy through multivariate analysis of optical parameters.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If scattergram method is used to determine bacterial types, then bacterial classification can be achieved, but it is difficult to determine multiple types of bacteria and provide detailed information

Engineering Contradiction:
Improvebacterial classification accuracyVSAvoidbacterial type differentiation information
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The patent segments the bacterial population into distinct groups based on multiple optical parameters (forward scatter, side scatter, fluorescence). By dividing the data space into multiple dimensions and using threshold-based classification, the system can differentiate between multiple bacterial types simultaneously, providing detailed information about each type's characteristics.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent transitions from two-dimensional scattergram analysis to multi-dimensional parameter space analysis. By incorporating multiple optical parameters (size, shape, fluorescence intensity, fluorescence spectrum) simultaneously, the system creates a higher-dimensional classification framework that enables differentiation of multiple bacterial types that cannot be resolved in lower-dimensional representations.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Reliability

If traditional detection methods are used, then bacteria can be detected, but it is difficult to monitor bacterial changes over time and assess treatment effectiveness

Engineering Contradiction:
Improvebacteria detection reliabilityVSAvoidbacterial change information
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The patent implements a feedback mechanism by comparing current bacterial characteristics with historical data stored in memory. The system automatically detects changes in bacterial types, sizes, and fluorescence patterns over time, providing real-time feedback on disease progression and treatment response. This enables continuous monitoring and dynamic adjustment of treatment strategies.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent establishes continuous monitoring capability by enabling repeated measurements of the same sample over time. The system maintains continuous data collection and comparison, allowing tracking of bacterial dynamics throughout the disease course and treatment period, thereby providing uninterrupted information on bacterial changes without requiring repeated sample collection.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables rapid and accurate identification of urinary tract infections and changes in bacterial types, improving diagnostic precision and treatment monitoring by providing prompt and detailed analysis of bacterial compositions.

Implementation Method 1

a light source for emitting light to particles contained in a measurement sample which is prepared from a reagent and a urine sample collected from a subject; a detector for detecting scattered light and fluorescence which are generated from the particles in the measurement sample

Methodology Applied
Scientific EffectScattered light: Scattering

Implementation Method 2

a detector for detecting scattered light and fluorescence which are generated from the particles in the measurement sample

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS9086402B2Sample analyzer
Publication Date: 2015.07.21 SYSMEX CORP
  • US9086402B2 patent drawing
  • US9086402B2 patent drawing
  • US9086402B2 patent drawing

AI summary

A sample analyzer comprising: a light source for emitting light to particles contained in a measurement sample which is prepared from a reagent and a urine sample collected from a subject; a detector for detecting scattered light and fluorescence which are generated from the particles in the measurement sample; a display; and a controller, wherein the controller executes operations comprising: obtaining particle data based on the scattered light and the fluorescence which are detected from the particles by the detector; and controlling, when the particle data satisfies a predetermined condition, the display to display information indicating a possibility that the subject is infected with an uncomplicated urinary tract infection is disclosed.